This is not the most recent version of the article. View current version (26 JUL 2013)

Intervention Review

Insulin and oral agents for managing cystic fibrosis-related diabetes

  1. Gary M Onady1,*,
  2. Adrienne Stolfi2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 3 NOV 2008

DOI: 10.1002/14651858.CD004730.pub2


How to Cite

Onady GM, Stolfi A. Insulin and oral agents for managing cystic fibrosis-related diabetes. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD004730. DOI: 10.1002/14651858.CD004730.pub2.

Author Information

  1. 1

    Wright State University, Boonshoft School of Medicine, Dayton, Ohio, USA

  2. 2

    Children's Medical Center, Department of Pediatrics, Dayton, Ohio, USA

*Gary M Onady, Boonshoft School of Medicine, Wright State University, Room 105, Medical Sciences Building, 3640 Colonel Glenn Highway, Dayton, Ohio, OH 45435, USA. gmonady@gmail.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

This is not the most recent version of the article. View current version (26 JUL 2013)

  1. You have free access to this content

    Current Version

    Insulin and oral agents for managing cystic fibrosis-related diabetes

    Gary M Onady and Adrienne Stolfi

    Article first published online: 26 JUL 2013 | DOI: 10.1002/14651858.CD004730.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Insulin and oral agents for managing cystic fibrosis-related diabetes

    Gary M Onady and Adrienne Stolfi

    Article first published online: 20 JUL 2005 | DOI: 10.1002/14651858.CD004730.pub2

  2. Version 1

    Insulin and oral agents for managing cystic fibrosis-related diabetes

    GM Onady and A Stolfi

    Article first published online: 19 APR 2004 | DOI: 10.1002/14651858.CD004730